BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cazzola M, Barosi G, Bergamaschi G, Dezza L, Palestra P, Polino G, Ramella S, Spriano P, Ascari E. Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol. 1983;54:649-654. [PMID: 6871111 DOI: 10.1111/j.1365-2141.1983.tb02145.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Bird AR, Knottenbelt E, Jacobs P, Maigrot J. Primary shunt hyperbilirubinaemia: a variant of the congenital dyserythropoietic anaemias. Postgrad Med J. 1991;67:396-398. [PMID: 2068039 DOI: 10.1136/pgmj.67.786.396] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
2 Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 2006;107:334-40. [PMID: 16141353 DOI: 10.1182/blood-2005-01-0421] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
3 Ohisalo JJ, Viitala J, Lintula R, Ruutu T. A new congenital dyserythropoietic anaemia. Br J Haematol 1988;68:111-4. [DOI: 10.1111/j.1365-2141.1988.tb04187.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
4 Fargion S, Valenti L, Fracanzani AL, Sampietro M, Cappellini MD, Scaccabarozzi A, Soligo D, Mariani C, Fiorelli G. Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia. Blood 2000;96:3653-5. [DOI: 10.1182/blood.v96.10.3653] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
5 Beutler E, Hoffbrand AV, Cook JD. Iron Deficiency and Overload. Hematology 2003;2003:40-61. [DOI: 10.1182/asheducation-2003.1.40] [Cited by in Crossref: 102] [Cited by in F6Publishing: 80] [Article Influence: 5.7] [Reference Citation Analysis]
6 Malcovati L, Cazzola M. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts. Br J Haematol 2016;174:847-58. [PMID: 27391606 DOI: 10.1111/bjh.14215] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
7 Gordeuk VR, McLaren GD, Samowitz W. Etiologies, consequences, and treatment of iron overload. Crit Rev Clin Lab Sci 1994;31:89-133. [PMID: 7917009 DOI: 10.3109/10408369409084674] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cazzola M, Malcovati L. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing. Hematology 2015;2015:19-25. [DOI: 10.1182/asheducation-2015.1.19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
9 Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood. 2003;102:4576-4581. [PMID: 12933587 DOI: 10.1182/blood-2003-02-0613] [Cited by in Crossref: 72] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
10 Lavabre-bertrand T, Ramos J, Delfour C, Henry L, Guiraud I, Carillo S, Wagner A, Bureau JP, Blanc P. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I: Interferon for CDA type I. European Journal of Haematology 2004;73:380-3. [DOI: 10.1111/j.1600-0609.2004.00310.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
11 Hofmann W, Kaltwasser J, Hoelzer D, Nielsen P, Gabbe E. Successful Treatment of Iron Overload by Phlebotomies in a Patient With Severe Congenital Dyserythropoietic Anemia Type II. Blood 1997;89:3068-3068. [DOI: 10.1182/blood.v89.8.3068] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zanella A, Berzuini A, Colombo MB, Guffanti A, Lecchi L, Poli F, Cappellini MD, Barosi G. Iron status in red cell pyruvate kinase deficiency: study of Italian cases. Br J Haematol 1993;83:485-90. [PMID: 8485056 DOI: 10.1111/j.1365-2141.1993.tb04675.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zamboni P, Izzo M, Fogato L, Carandina S, Lanzara V. Urine hemosiderin: A novel marker to assess the severity of chronic venous disease. Journal of Vascular Surgery 2003;37:132-6. [DOI: 10.1067/mva.2003.64] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
14 Malcovati L. Red Bood Cell Transfusion Therapy and Iron Chelation in Patients With Myelodysplastic Syndromes. Clinical Lymphoma and Myeloma 2009;9:S305-11. [DOI: 10.3816/clm.2009.s.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Marks PW, Mitus AJ. Congenital dyserythropoietic anemias. Am J Hematol 1996;51:55-63. [DOI: 10.1002/(sici)1096-8652(199601)51:1<55::aid-ajh9>3.0.co;2-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Van Steenbergen W, Matthijs G, Roskams T, Fevery J. NONIATROGENIC HAEMOCHROMATOSIS IN CONGENITAL DYSERYTHROPOIETIC ANAEMIA TYPE II IS NOT RELATED TO C282Y AND H63D MUTATIONS IN THE HFE GENE : REPORT ON TWO BROTHERS. Acta Clinica Belgica 2014;57:79-84. [DOI: 10.1179/acb.2002.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
17 Origa R, Cazzola M, Mereu E, Danjou F, Barella S, Giagu N, Galanello R, Swinkels DW. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia. Haematologica 2015;100:e169-71. [PMID: 25596269 DOI: 10.3324/haematol.2014.115733] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
18 Taylor MD, Allada V, Moritz ML, Nowalk AJ, Sindhi R, Aneja RK, Torok K, Morowitz MJ, Michaels M, Carcillo JA. Use of C-Reactive Protein and Ferritin Biomarkers in Daily Pediatric Practice. Pediatr Rev 2020;41:172-83. [PMID: 32238546 DOI: 10.1542/pir.2018-0101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kardos G, Veerman A, de Waal F, van Oudheusden L, Slater R. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome. Med Pediatr Oncol 1996;26:54-6. [DOI: 10.1002/(sici)1096-911x(199601)26:1<54::aid-mpo7>3.0.co;2-u] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
20 Cazzola M, Della Porta MG, Malcovati L. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 2008;:166-75. [PMID: 19074076 DOI: 10.1182/asheducation-2008.1.166] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
21 Danise P, Amendola G, Nobili B, Perrotta S, Miraglia Del Giudice E, Matarese SM, Iolascon A, Brugnara C. Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis. Clin Lab Haematol 2001;23:7-13. [PMID: 11422224 DOI: 10.1046/j.1365-2257.2001.00354.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
22 Dykes A, Gürtler V, Firkin F. Aetiology of severe iron overload in a family with hereditary haemolytic anaemia: Short Report. British Journal of Haematology 1998;102:1179-81. [DOI: 10.1046/j.1365-2141.1998.00918.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Cazzola M, De Stefano P, Ponchio L, Locatelli F, Beguin Y, Dessi C, Barella S, Cao A, Galanello R. Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol. 1995;89:473-478. [PMID: 7734344 DOI: 10.1111/j.1365-2141.1995.tb08351.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 2.7] [Reference Citation Analysis]
24 Hewitt PE, Win AA, Davies SC. CDA TYPE I WITH PERSISTENT HAEMOSIDERINURIA: ABSENCE OF IRON LOADING. Br J Haematol 1984;56:682-4. [DOI: 10.1111/j.1365-2141.1984.tb02194.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
25 Shalev H, Kapleushnik Y, Haeskelzon L, Degani O, Kransnov T, Sphilberg O, Moser A, Yaniv I, Tamary H. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults: CDA type I in young adults. European Journal of Haematology 2002;68:170-4. [DOI: 10.1034/j.1600-0609.2002.01663.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
26 van Waveren Hogervorst GD, van Roermund HP, Snijders PJ. Hereditary sideroblastic anaemia and autosomal inheritance of erythrocyte dimorphism in a Dutch family. Eur J Haematol 1987;38:405-9. [PMID: 3653362 DOI: 10.1111/j.1600-0609.1987.tb01436.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
27 Cazzola M, Invernizzi R. Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationship. Haematologica 2010;95:693-5. [PMID: 20442439 DOI: 10.3324/haematol.2009.021683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Vassiliadis T, Garipidou V, Perifanis V, Tziomalos K, Giouleme O, Patsiaoura K, Avramidis M, Nikolaidis N, Vakalopoulou S, Tsitouridis I, Antoniadis A, Semertzidis P, Kioumi A, Premetis E, Eugenidis N. A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis. World J Gastroenterol 2006;12:818-21. [PMID: 16521204 DOI: 10.3748/wjg.v12.i5.818] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Zanella A, Bianchi P, Iurlo A, Boschetti C, Taioli E, Vercellati C, Zappa M, Fermo E, Tavazzi D, Sampietro M. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. Blood Cells Mol Dis. 2001;27:653-661. [PMID: 11482880 DOI: 10.1006/bcmd.2001.0433] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
30 Harris JW, Danish EH, Brittenham GM, Mclaren CE. Pyridoxine responsive hereditary sideroblastic erythropoiesis and iron overload: Two microcytic subpopulations in the affected male, one normocytic and one microcytic subpopulation in the obligate female carrier. Am J Hematol 1993;42:400-1. [DOI: 10.1002/ajh.2830420415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
31 Cazzola M, Beguin Y, Bergamaschi G, Guarnone R, Cerani P, Barella S, Cao A, Galanello R. Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol. 1999;106:752-755. [PMID: 10468869 DOI: 10.1046/j.1365-2141.1999.01600.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
32 Russo R, Esposito MR, Iolascon A. Inherited hematological disorders due to defects in coat protein (COP)II complex. Am J Hematol 2013;88:135-40. [PMID: 22764119 DOI: 10.1002/ajh.23292] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
33 Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 2005;131:431-46. [DOI: 10.1111/j.1365-2141.2005.05757.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
34 Zanella A, Barosi G, Berzuini A, Colombo MB, Quaglini S, Volpes D, Sirchia G. Relative iron deficiency in hereditary spherocytosis. Am J Hematol 1989;31:81-6. [DOI: 10.1002/ajh.2830310202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
35 May A, Fitzsimons E. 6 Sideroblastic anaemia. Baillière's Clinical Haematology 1994;7:851-79. [DOI: 10.1016/s0950-3536(05)80128-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
36 Kremer Hovinga JA, Solenthaler M, Dufour JF. Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases. Eur J Gastroenterol Hepatol. 2003;15:1141-1147. [PMID: 14501626 DOI: 10.1097/00042737-200310000-00014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]